Zepp Health Corporation Sponsored ADR (NYSE:ZEPP - Get Free Report)'s share price was up 6.4% on Wednesday . The company traded as high as $48.99 and last traded at $48.70. Approximately 42,637 shares traded hands during trading, a decline of 85% from the average daily volume of 289,342 shares. The stock had previously closed at $45.78.
Analysts Set New Price Targets
ZEPP has been the subject of a number of recent research reports. Fundamental Research set a $60.23 price objective on shares of Zepp Health and gave the stock a "buy" rating in a report on Tuesday, August 26th. Wall Street Zen upgraded Zepp Health to a "hold" rating in a research note on Saturday, August 16th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $60.23.
Check Out Our Latest Analysis on ZEPP
Zepp Health Stock Performance
The stock has a market cap of $707.67 million, a P/E ratio of -10.10 and a beta of 1.33. The firm has a 50 day moving average of $36.91 and a two-hundred day moving average of $15.16. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.78 and a current ratio of 1.10.
Zepp Health Company Profile
(
Get Free Report)
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Zepp Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zepp Health wasn't on the list.
While Zepp Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.